8/29/17 Flashcards
Hyperglycemia Symptoms
Frequent urination (polyuria) Thirst (polydipsia) Blurry vision Fatigue Hunger Weight loss
Screen and diagnose diabetes
Fasting Blood Glucose-
Normal: <100 mg/dl
Diabetes: >125 mg/dl
HbA1c-
Normal: <5.7%
Diabetes: >6.5%
2 hour oral glucose tolerance test-
Normal: <140 mg/dl
Diabetes: >200 mg/dl
Test should be considered for overweight adults (BMI >25) with risk factors like race, relatives, sedentary lifestyle, dyslipidemia, Hypertension, and acanthosis nigricans
Low risk patient screening: start testing at 45 years old, repeat every 3 years or yearly if prediabetic
Mess for type II diabetes
Goal is to lower glucose
Pancreas: sulfonylurea and meglitinides enhance insulin secretion (insulin secretagogues) by inhibiting beta cell K+/ATP channel and binding to SUR1, GLP-1 analogues and DPP4-inhibitors up insulin secretion and lower glucagon secretion
Liver: metformin inhibits gluconeogenesis
Gut: Acarbose (Amy Lin analogue) and Alpha-glucosidase inhibitors reduce glucose absorption
Reduce endogenous glucose production- biguanides and bile acid sequestrants
Muscle: thiazolidinediones address insulin resistance by increasing insulin sensitivity
Kidney: SGLT2 inhibitors block renal glucose reabsorption
A1C % reduction- 0.5%: DPP4 inhibitors 1%: SGLT2 inhibitors 1.5%: TZDs and GLP-1 2%: Metformin and sulfonylurea
Pathophysiology of Type II
Peripheral insulin resistance
Progressive beta cell dysfunction: lower mass and function, accompanied by inadequate insulin secretion
Hypersecretion of glucagon: elevates blood sugar due to increased hepatic output, glucagon not suppressed after meals like it should be
Gastric Emptying: potentiates postprandial glucose levels
Impaired incretin effects: contributes to elevated postprandial glucose levels, have less insulin potentiation than normal
Incretin Response
Difference between oral glucose load and intravenous glucose infusion
Type II diabetics have lower incretin response
Incretin normal physiology
Secreted from L-cells of jejunum and ileum in a biphasic manner
Suppresses glucagon Secretion and stimulates glucose-dependent insulin secretion
Slows gastric emptying, reduces rate of nutrient absorption and slow the rate of glucose apparent in blood
Animal studies show increase beta cell mass and improve function